A Financial Analysis and Risk Assessment of Healthcare Companies

In the post-pandemic era, the growing global interest in healthcare has driven substantial changes in the healthcare industry. Because of the pandemic's enormous effects on economic development and human life, it is critical to turn the experience into practical lessons learned in order to avoid future crises, and this paper is about analyzing and improving healthcare services with an economic perspective. Through an analysis of the financial performance and risk assessment of three healthcare companies, UnitedHealth Group(UNH), CVS Health Corporation(CVS) and Pfizer(PFE)--this paper investigates the economics of this sector. The financial performance of these companies is assessed by collecting relevant information from multiple online data sources for comparative analysis, including key financial metrics such as current ratio, debt ratio, PE ratio, and ROA, ROE. The findings reveal the financial strengths and weaknesses of these companies and provide valuable insights into understanding the economic development of the healthcare industry. The paper ends with conclusions that analyze investor investment preferences and provide recommendations and future directions for addressing risks in an increasingly changing healthcare environment.